DHFR and obstructive sleep apnea syndrome: All five OSA cell lines, which were derived from diagnostic biopsies of primary tumors without any previous neoadjuvant chemotherapy, were significantly more resistant to the DHFR-mediated effect of MTX than Saos-2 cell line.